Ron Bentsur - 17 Nov 2022 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ron Bentsur
Issuer symbol
NVCT
Transactions as of
17 Nov 2022
Net transactions value
+$5,425
Form type
4
Filing time
21 Nov 2022, 07:39:24 UTC
Previous filing
16 Nov 2022
Next filing
29 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $1,810 +250 +0.01% $7.24 3,014,359 17 Nov 2022 Direct F1
transaction NVCT Common Stock Purchase $3,615 +500 +0.02% $7.23 3,014,859 18 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 96,759 shares of restricted stock and 120,000 restricted stock units.